ArticleInfectious Disease Modelling2026
Predicting the spatiotemporal evolution of HIV/AIDS in Africa: A retrospective analysis of epidemiological trends.
Article in Infectious Disease Modelling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Africa bears the highest global burden of HIV, with marked regional inequalities in prevalence, incidence and clinical outcomes. Mapping the spatial and temporal evolution of the epidemic is essential to guide targeted interventions and anticipate future trends. Methods: We conducted a retrospective analysis of UNAIDS annual estimates for adults aged 15-49 years across 49 African countries (2014-2023). We described spatiotemporal patterns in HIV prevalence, incidence, adults living with HIV (ALHIV) and AIDS-related deaths, and quantified temporal trends using annual percentage change and linear regression. For the ten highest-burden countries, we forecast prevalence to 2033 using an ensemble of machine learning models. Hierarchical and k-means clustering, supported by principal component analysis, were applied to identify epidemic archetypes based on average prevalence levels and temporal trajectories. Results: Southern Africa remained the epicentre of the epidemic, with mean adult prevalence of 19.97% versus <1.3% in Northern and Western Africa. From 2014 to 2023, prevalence and incidence declined in all regions, with the steepest reductions in Southern (prevalence -19.5%; incidence -68.4%) and Eastern Africa (-22.2% and -65.6%, respectively). Despite falling rates, the absolute number of ALHIV increased in several regions, while AIDS-related deaths decreased by more than 44% in Central and Western Africa. Forecasts for the highest-burden countries indicate a continued, gradual decline in prevalence. Cluster analysis identified a hyperendemic group of six Southern African countries (mean prevalence 15.6%) and a second cluster of 41 countries with moderate-to-low prevalence (2.1%) and mainly stable or declining trajectories. Conclusions: The African HIV epidemic is increasingly heterogeneous and evolving rather than uniformly controlled. Combining machine learning forecasts and clustering with routine surveillance can support differentiated, data-driven strategies that intensify prevention and treatment in hyperendemic settings while sustaining gains elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.